Nam Song Choi Selected Research

methyl- 4- (3- chloro- 4- methoxybenzylamino)- 8- (2- hydroxyethyl)- 7- methoxyquinazolin- 6- ylmethylcarbamate

1/2010

Discovery of potent, selective, and orally bioavailable PDE5 inhibitor: Methyl-4-(3-chloro-4-methoxybenzylamino)-8-(2-hydroxyethyl)-7-methoxyquinazolin-6-ylmethylcarbamate (CKD 533).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nam Song Choi Research Topics

Disease

2	Neoplasms (Cancer) 11/2010 - 09/2010
2	Erectile Dysfunction 01/2010 - 12/2008
1	Endotoxemia 12/2013
1	Myeloid Leukemia (Leukemia, Myelocytic) 03/2007

Drug/Important Bio-Agent (IBA)

2	ProdrugsIBA 11/2010 - 09/2010
2	Tubulin ModulatorsIBA 11/2010 - 09/2010
2	Valine (L-Valine)FDA Link 11/2010 - 09/2010
1	Chlorogenic AcidIBA 12/2013
1	Amino Acids FDA Link 11/2010
1	N- (4- (3- (1H- 1,2,4- triazol- 1- yl)- 4- (3,4,5- trimethoxybenzoyl)phenyl)thiazol- 2- yl)- 2- amino- 3- methylbutanamideIBA 09/2010
1	methyl- 4- (3- chloro- 4- methoxybenzylamino)- 8- (2- hydroxyethyl)- 7- methoxyquinazolin- 6- ylmethylcarbamateIBA 01/2010
1	QuinazolinesIBA 12/2008
1	Phosphodiesterase 5 InhibitorsIBA 12/2008
1	EthersIBA 03/2007

Therapy/Procedure

1	Therapeutics 12/2008